From: Efficacy of telavancin for treatment of surgical site infections
TLV SA
VAN SA
TLV MRSA
VAN MRSA
Clinical cure, n (%)
41 (85)
33 (70)
18 (86)
15 (71)
Pathogen eradication, n (%)
40 (83)
30 (64)
17 (81)
12 (57)